Koers VIA Pharmaceuticals, Inc. Other OTC
Aandelen
VIAP
US92554T1034
Biotechnologie & Medisch Onderzoek
Omzet 2009 | - | Omzet 2010 | - | Marktkapitalisatie | 822K 758K |
---|---|---|---|---|---|
Nettowinst (verlies) 2009 | -21 mln. -19,36 mln. | Nettowinst (verlies) 2010 | -9 mln. -8,3 mln. | EV/omzet 2009 | - |
Nettoschuld 2009 | 7,81 mln. 7,2 mln. | Nettoschuld 2010 | 13,92 mln. 12,83 mln. | EV/omzet 2010 | - |
K/w-verhouding 2009 |
-0,19
x | K/w-verhouding 2010 |
-0,08
x | Werknemers | - |
Dividendrendement 2009 * |
-
| Dividendrendement 2010 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 70 | 01-07-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 70 | 01-07-04 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+67,53% | 63,85 mld. | |
-0,77% | 41,83 mld. | |
+45,66% | 40,65 mld. | |
-10,72% | 27,12 mld. | |
+13,30% | 26,52 mld. | |
-22,79% | 18,69 mld. | |
+4,70% | 12,73 mld. | |
+24,10% | 12,11 mld. | |
+27,41% | 12,07 mld. |